Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States by Zinan Yi, Kwame Owusu-Edusei, Elamin Elbasha

Get full text

Lifetime Health and Economic Burden of Invasive Pneumococcal Diseases Attributable to V116 Serotypes Among Adults in the United States by Zinan Yi, Kelly D. Johnson, Kwame Owusu-Edusei

Get full text

Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom by Kwame Owusu-Edusei, Cody Palmer, Olga Ovcinnikova, Giampiero Favato, Vincent Daniels

Get full text

Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population by Min Huang, Tianyan Hu, Jessica Weaver, Kwame Owusu-Edusei, Elamin Elbasha

Get full text

Cost-Effectiveness of Pneumococcal Vaccination in Adults in Italy: Comparing New Alternatives and Exploring the Role of GMT Ratios in Informing Vaccine Effectiveness by Vincenzo Restivo, Vincenzo Baldo, Laura Sticchi, Francesca Senese, Gian Marco Prandi, Linde Pronk, Kwame Owusu-Edusei, Kelly D. Johnson, Tim Ignacio

Get full text

Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts by Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Cody Palmer, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan Simpson, Vincent Daniels, Elamin Elbasha

Get full text